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Summary
Heparan sulfates (HSs) are extraordinarily complex extracellu-
larsugarmolecules thatarecriticalcomponentsofmultiplesig-
naling systems controlling neuronal development [1–3]. The
molecular complexityofHSsarises throughaseriesof specific
modifications, including sulfations of sugar residues and epi-
merizations of their glucuronic acid moieties. The modifica-
tions are introduced nonuniformly along protein-attached HS
polysaccharide chains by specific enzymes [4]. Genetic analy-
sis has demonstrated the importance of specific HS-modifica-
tion patterns for correct neuronal development [2, 3]. However,
it remains unclear whether HS modifications provide a merely
permissive substrate or whether they provide instructive pat-
terning information during development. We show here with
single-cell resolution that highly stereotyped motor axon pro-
jections inC. elegans depend on specific HS-modification pat-
terns. By manipulating extracellular HS-modification patterns,
we can cell specifically reroute axons, indicating that HSmod-
ificationsare instructive.Thisaxonal rerouting isdependenton
the HS core protein lon-2/glypican and both the axon guidance
cue slt-1/Slit and its receptor eva-1. These observations sug-
gest that a changed sugar environment instructs slt-1/Slit-
dependent signaling via eva-1 to redirect axons. Our experi-
ments provide genetic in vivo evidence for the ‘‘HS code’’
hypothesis which posits that specific combinations of HS
modifications provide specific and instructive information to
mediate the specificity of ligand/receptor interactions [3, 5, 6].
Results
Distinct HS-Modification Patterns Are Required
by Individual Ventral Cord Motor Neurons for Correct Axon
Pathfinding
The DA and DB classes of motor neurons are embryonically
generated motor neurons (eMNs) in the ventral nerve cord
*Correspondence: hbuelow@aecom.yu.edu(VNC) of C. elegans. Individual DA and DB motor neurons
make differential, completely invariant choices as to whether
to extend circumferentially along the right or left side of the
animal (Figures 1B–1D). This sidedness does not correlate
with the membership of a motor neuron to a specific class
(e.g., two DA neurons extend along the right side, and seven
DA neurons extend to the left side; Table S1 available online),
nor position along the a/p axis (Figure 1B; Table S1), lineage
history (Table S1), or any other unique cellular landmark in their
environment (Table S1). Intriguingly, there are no molecular
markers that distinguish individual DA neurons or individual
DB neurons from one another (i.e., no genes are known that
are expressed in DB2 but not DB3) and no genes have been
reported that control the cell-type specificity of the projection
patterns. To test whether individual DA/DB motor neurons
require distinct HS modifications for correct development,
we genetically removed three major HS-modifying enzymes,
the C5-epimerase encoded by hse-5, the 6O-sulfotransferase
encoded by hst-6, and the 2O-sulfotransferase, encoded by
hst-2 (Figures 1A and 1E). Because none of these enzymes
have paralogs in C. elegans, we can assume that animals
with null mutations in these genes completely lack C5-epime-
rization, 6O-sulfation, or 2O-sulfation [7]. Removal of C5-
epimerization or 2O-sulfation each result in mild defects in
the sidedness of motor axon projections [7]. These mild de-
fects show cell-type specificity, with DA2, DB3, DB6, and
DB7 being most affected by loss of 2O-sulfation (Figure 1E).
Generation of double mutants as well as a triple mutant re-
sulted in significantly enhanced mutant phenotypes, revealing
cell-type-specific redundancies in the requirement of HS mod-
ifications for individual motor axons (Figure 1F). For example,
the DA2, DB3, and DB6 motor neurons display significantly
enhanced defects in the hst-6 hst-2 and hse-5; hst-6 double
mutant combinations, indicating that hst-6 function is redun-
dant with both hse-5 and hst-2 in these motor neurons. How-
ever, in DA6 motor neurons, hst-6 function is redundant with
hse-5 but not with hst-2, whereas, in DB5 motor neurons,
hst-6 is redundant with hst-2 but not with hse-5 (Figure 1F).
The HS-modification enzymes hst-6 and hst-2/hse-5 appear
to act in different tissues during neuronal development, with
hst-6 acting in neuronal tissues and hse-5/hst-2 in hypodermal
tissues [7]. Thus, the observation that hst-6 and hse-5/hst-2
serve redundant functions in some neurons may seem nonin-
tuitive given their disparate sites of action. However, HS
has been demonstrated to act cell nonautonomously in, for
example, ectodermal/mesodermal interactions [8]. It is there-
fore conceivable that differentially modified HS on neuronal
and hypodermal tissues cooperate in a redundant manner to
control axon routing.
In contrast, the defects in hse-5; hst-2 double mutants are no
more severe than the defects in the most severe (hst-2) of the
single mutants (Figure 1F). This last finding is consistent with
analyses in other cellular contexts that demonstrate that
hse-5 and hst-2 can genetically act in the same pathway [7]. Fi-
nally, no further enhancement is observed in the triple mutant
combination compared to the hst-6 hst-2 double null mutant
(Figure 1F). We conclude that individual members of the
same class of motor neurons (DA or DB) that make apparently
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1979identical guidance choices at the ventral midline of C. elegans
are dependent on different combinations of HS modifications.
Removal of the HS core protein syndecan (sdn-1) recapitu-
lates the defects observed in hse-5; hst-6 hst-2 triple mutants,
both in terms of penetrance and cell-type specificity (Figures
1E and 1F). In contrast, neither null mutations in the two
C. elegans glypican HS core proteins (gpn-1 and lon-2; [9, 10])
nor mutations in the secreted HS core proteins unc-52 (perle-
can; [11]) or cle-1 (collagen XVIII; [12]) display significant de-
fects in eMN left/right projection patterns (Figure S1A). These
results suggest that the majority of HS that controls DA/DB mo-
tor axon choices may be attached to the syndecan core protein.
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Figure 1. Individual DA/DB Motor Neurons Re-
quire Distinct Combinations of HS Modifications
(A) Heparan sulfate is a polymer composed of
highly modified disacharide repeats that is at-
tached to a core protein. Shown is a characteristic
HS disaccacharide repeat unit consisting of a
hexuronic acid (circle) and a glucosamine (hexa-
gon) residue and enzymes that modify this struc-
ture. Large blue versus black circles indicate idur-
onic acid versus glucuronic acid, respectively.
Small circles in black, green, and red indicate
modifications as color coded in the disaccharide
repeat. HSE-5, HS C5 epimerase; HST-X, HS
XO-sulfotransferase (X = 2, 6).
(B) The top panel shows the circumferential
axonal trajectory of exemplary DA-, DB-, and
DD-type eMNs. eMNs are distinguished by their
axonal projection patterns and by the neurotrans-
mitter, which they express. The lower panel
shows a schematic ‘‘open book’’ representation
of the 2- to 3-fold embryonic stage when eMN
axon outgrowth occurs, illustrating that individual
DA, DB eMNs show a distinct sidedness of cir-
cumferential axonal growth. The eMN cell bodies
shown here lie on top of the junctions between bi-
laterally symmetry P1/2, P3/4, P5/6, P7/8, P9/10,
and P11/12 hypodermal cells. More anteriorly
and posteriorly positioned eMNs are not shown
(see Experimental Procedures). The only other
axon that populates the VNC at that stage is the
axon of the AVG pioneer neuron. See Table S1
for a systematic comparison of individual motor
neuron class members.
(C) Visualizing the DA and DB motor axons with an
unc-129::gfp-expressing transgene.
(D) The left/right asymmetric, circumferential DA,
DB axon projection patterns are highly stereo-
typed. We focus our scoring on the DA2 to DA6
and DB3 to DB7 motor neurons because those
express the gfp reporter transgene most reliably.
‘‘% defect.’’ indicates percentage of animals with
a defective sidedness of the respective DA or DB
axon as indicated.
(E) Loss of HS modifications affect DA and DB
axon choices in a cell-type-specific manner. All
mutants used are null mutants [7, 31]. Single
mutants were statistically compared to wild-type
(see [D]); ns, not significantly different; *p < 0.05,
**p < 0.005.
(F) Comparison of effects of single, double, and
triple HS mutants on specific motor axons. Double
mutants were statistically compared to the more
severe of two respective single mutants; ns,
not significantly different; *p < 0.05, **p < 0.005,
***p < 0.0005. The defects in both DA2 and DB3
are weakly statistically significant when compar-
ing the triple hse-5; hst-6 hst-2 mutant and the
sdn-1/syndecan null mutant (p = 0.04 and 0.03, re-
spectively). However, these differences are not
significant between the hst-6 hst-2 double mutant
and either the sdn-1/syndecan mutant or the
hse-5; hst-6 hst-2 triple mutant, suggesting that
the phenotype of the sdn-1 and the hse-5; hst-6
hst-2 triple mutant is very similar. Error bars
denote the standard error of proportion. See
Experimental Procedures for statistics.
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Figure 2. Manipulating HS-Modification Patterns Redirects Motor Axons
(A) Schematic view of the ventral cord with HS modifications in the hypodermis indicated by colored hatchings. Note that unlike in larvae, the embryonic
midline, defined as a physical barrier between the left and right ventral fascicles, is not constituted by a hypodermal evagination but by motor neuron
cell bodies [32].
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1981Manipulating HS-Modification Patterns Redirect Motor
Axon Projections
Our present work with DA/DB motor neurons together with
previous work shows that the function of HS requires their
extensively modified polysaccharide chains (Figure 1A; re-
viewed in [3, 13]). However, it is unclear whether HS modifica-
tions constitute a merely permissive environment or whether
they are sufficient to guide growing axons. The question of
permissiveness versus instructiveness represents one of the
key problems in the HS field [3, 13].
To address whether HS modifications are sufficient to guide
axons, i.e., serve instructive functions, we manipulated
HS-modification patterns by inducing ectopic 6O-sulfation in
the hypodermal cells that underlie the DA/DB motor neurons
(Figure 2A). The 6O-sulfotransferase hst-6 does not appear
to be expressed in hypodermal cells [7] (Figure 2A) and as
shown above, DA/DB axon choices are unaffected by removal
of hst-6 alone (Figure 1E). To alter HS-modification patterns
presented by hypodermal cells, we generated multiple trans-
genicC. elegans lines that aberrantly express hst-6 in an other-
wise wild-type background under control of the hypodermis-
specific dpy-7 promoter [14]. Worms expressing this construct
show an altered status of HS-modification patterns. First, we
detect novel staining patterns with an antibody that recog-
nizes HS epitopes comprising specific oligosaccharides rather
than individual modifications (Figure 2B) [15]. This antibody
labels the anterior intestine and possibly some neurons and
basement membranes in wild-type animals (not shown).
However, increased staining is observed consistently in the
hypodermis upon misexpression of hst-6 in this tissue. This
increased staining pattern is not observed in nontransgenic
but otherwise isogenic controls (Figure 2B). And second, bio-
chemical analyses of HS from transgenic worms expressing
hst-6 in the hypodermis display an increase of 6O-sulfated
relative to 2O-sulfated HS disaccharides (Figure S2). Each
transgenic line shows a significant number of animals in which
the projections of individual DA and DB motor neurons are
rerouted (Figures 2C and 3A; Figure S3). These defects are
not the result of apparent changes in cell fate or structure of
hypodermal cells misexpressing hst-6 (Figure 2E), nor are
they due to changes in eMN positioning in the VNC (data not
shown). Moreover, we cannot detect obvious disruptions of
the basement membranes surrounding eMNs and therefore
consider it unlikely that ectopic hst-6 expression grossly
disrupts midline structures (Figure 2F).
The axonal misrouting defects we observe are the result of
hst-6 activity as the introduction of a premature stop codon
into the hst-6 expression construct abolishes its ability toanterior to the left.induce axon misrouting (Figure 3A). Furthermore, no compara-
ble misrouting defects can be observed upondpy-7prom-driven
overexpression of the HS 2O-sulfotransferasehst-2 (Figure 3A),
which is normally expressed in both neuronal and hypodermal
tissues [7]. These hst-2 expressing transgenes are functional:
First, the transgenes are able to effectively rescue neuronal
hst-2 loss-of-function phenotypes (Figure S4A); second, by
using an antibody recognizing specific HS epitopes, we detect
increased staining in transgenic, hst-2-overexpressing strains
(Figure S4B); third, biochemical analyses of hst-2-overex-
pressing strains display increased 2O-sulfation relative to
6O-sulfation compared to wild-type (Figure S2). Together, our
results argue that the effects of ectopic hst-6 expression are
due to the regiospecific addition of a sulfate moiety to the
6O-hydroxyl group of the glucosamine residue, rather than
the unspecific addition of a negative charge.
Examining the axon choices of individual DA and DB motor
axons, we find that the defects induced by ectopic 6O-sulfation
are cell-type specific with all different transgenic lines display-
ing qualitatively similar misrouting patterns. Interestingly, there
seems to be a graded response of DB neurons to misexpressed
hst-6, with the more posterior neurons being more strongly af-
fected (Figure 3C; Figure S3). In contrast, within the DA class of
eMNs, only DA3 exhibits significant defects. Ectopic hypoder-
mal 6O-sulfation also causes axon guidance defects in a se-
lected number of other neurons in the nervous system. For
example, axon midline guidance of the PVQ interneurons is af-
fected (Figures 2D and 3B), whereas many neurons, such as
touch neurons, amphid, phasmid, and RMEV neurons display
no apparent defects (Table S2). Notably, PVQ interneurons
are also affected by loss of endogenous, neuronally acting
hst-6 [7]. The addition of 6O-sulfation in the wrong location (hy-
podermis) can therefore have the same detrimental effect for an
axon as not having 6O-sulfation in the correct place (neurons).
Taken together, manipulating HS modifications in the hypoder-
mis through addition of novel HS-modification patterns can
redirect axonal projections of individual neurons.
Ectopic 6O-Sulfation-Induced Motor Axon Misrouting
Requires Slit/slt-1 and Its Coreceptor eva-1
Most DA/DB motor neurons that respond to ectopic HS 6O-sul-
fation require hst-6 also for normal development in the absence
of hst-2 function (compare Figures 1E, 1F, and 3C). The excep-
tion is DB7, suggesting that DB7 axonal projections are nor-
mally independent of 6O-sulfated HS. However, upon hst-6
expression in the hypodermis, DB7 is misrouted, suggesting
that DB7 can be positively instructed by ectopic 6O-sulfated(B) Immunostaining with the AO4B08 HS-specific antibody [15] of transgenic animals, which ectopically express the HS-modification enzyme hst-6 in the
hypodermis (right; otIs176). Increased hypodermal staining observed in transgenic animals is not seen in isogenic controls, which do not ectopically express
hst-6 (left). Intestinal staining (not shown) serves as an internal staining control as does an unrelated synthetic antibody (MPB49), which shows no staining at
all. Note that the antibody AO4B08 does not recognize individual HS modifications but rather an oligosaccharide, which requires the activities of both hst-2
and hst-6 [15]. Because only hst-2 but not hst-6 appears to be expressed in the hypodermis [7], the observed staining of the hypodermis after misexpression
of hst-6 in this tissue is consistent with the known specificities of AO4B08. Note the aberrant projection of DB6 in the hst-6-misexpressing line (red arrow-
head).
(C) Axonal misrouting of DA/DB motor neurons in animals with ectopic hst-6 expression in the hypodermis (right, otEx1711). Dashed lines indicate neurons
that were not scored and affected neurons are in red. See Figure 3 and Figure S3 for quantification of defects.
(D) Midline crossover defects of PVQ interneurons in animals with ectopic hst-6 expression in the hypodermis (right, otEx1711).
(E) Hypodermal cell fate as well as cell morphology, as visualized by normal AJM-1 expression and localization patterns, is not visibly affected by ectopic
hst-6 expression (right, otIs176).
(F) Basement membrane topology, as visualized by a lam-1::gfp reporter (kind gift of David Sherwood) [33], is not visibly affected by ectopic hst-6 expression
(right, otIs176). Arrows point to the basement membrane that ensheathes the ventral midline and which visually appears most concentrated on each side of
the midline as a result of optical sectioning. Left panels represent wild-type controls in all cases. White arrowheads point to pharyngeal expression of gfp
denoting the presence of the hypodermal hst-6 misexpression array, and red arrowheads indicate axonal routing errors. All views are ventral aspects with
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Figure 3. Genetic Analyses of hst-6-Dependent
Axonal Misrouting Phenotypes
(A) Quantification of DA/DB motor neuron defects
in different transgenic strains that express the
indicated constructs from the hypodermal-
specific dpy-7 promoter. Shown is the percent-
age of animals with any number (R1 per animal)
of DA or DB axon sidedness defects.
(B) Quantification of midline crossover defects in
PVQ interneurons in different transgenic strains
that express hst-6 from the hypodermal-specific
dpy-7 promoter.
(C) Effect of ectopic hst-6 expression on individ-
ual DA and DB neurons. One representative line
is shown here, five more extrachromosomal lines
are shown in Figure S2B. Shown is the percent-
age of animals with defects in individual DA/DB
motor axons projections as indicated.
(D) Defects in DB7 motor axon projection patterns
in different mutants of the Slit/Robo signaling
pathway as indicated. Shown is the percentage
of animals with defects in DB7 motor axon projec-
tions.
(E) Effect of genetic removal of HS core proteins
on projection errors in DB7 motor axons as a
result of ectopic hst-6 expression. Shown is the
percentage of animals with defects in DB7 motor
neuron projections. Statistic comparisons are
made to the transgenic control. The projection
pattern of DB7 in animals that misexpress hst-6
in the hypodermis and are also mutant for lon-2
is statistically indistinguishable from nontrans-
genic, wild-type animals.
(F) Effect of removal of genes in the Slit/Robo
signaling pathway on projection errors in DB7
motor axons as a result of ectopic hst-6 expres-
sion. Shown is the percentage of animals with
defects in DB7 motor axon projections. Statistic
comparisons are made to the transgenic control.
The projection pattern of DB7 in animals that
misexpress hst-6 in the hypodermis and are
also mutant for slt-1 or eva-1 is statistically
indistinguishable from nontransgenic, wild-type
animals. Error bars denote the standard error of
proportion. Statistical significance is indicated
by ns, not significantly different; *p < 0.05, **p <
0.005, ***p < 0.0005 in all panels.HS. We therefore focus our genetic analyses here on the DB7
motor neuron.
We first asked which HS core protein would bear the ectopic
6O-sulfated HS presented by the hypodermis that misdirects
the DB7 motor neuron. To this end, we systematically removed
the genes coding for four canonical HS core proteins in the
C. elegans genome, lon-2/glypican, gpn-1/glypican, sdn-1/
syndecan, or unc-52/perlecan, respectively, and tested the
effect on DB7 motor neuron projection patterns in animals ex-
pressing hst-6 in the hypodermis. We find that removal of lon-
2/glypican but none of the other HS core proteins suppresses
the axonal misrouting of DB7 to a level that is statistically indis-
tinguishable from wild-type (Figure 3E). As lon-2/glypican
normally acts in the hypodermis [10], our data suggest that
the ectopic HS structures in the hypodermis that redirect
DB7 may be attached to the LON-2/glypican HS core protein.
We next sought to address how alterations in HS-modifica-
tion patterns exert an impact on the DB7 motor axon guidance
decision. HS may play a role in determining ligand/receptor
binding specificities in vitro (reviewed in [3]), so we reasoned
that changing HS-modification patterns may reprogram the re-
sponsiveness of motor axons to defined cues. To address this
possibility, we asked whether a specific axon guidance cue is
required for the misrouting of individual motor axons induced
by ectopic 6O-sulfation. The guidance cue slt-1/Slit is known
to require different HS modifications in distinct cellular con-
texts in C. elegans [7]. Slit-mediated axon growth at the fly
midline, and in vertebrate tissue explants, are also known to
require the presence of HS, albeit of unknown modification
status [16–18]. The ligand slt-1/Slit signals through sax-3/
Robo of the Robo family of guidance receptors [19]. More re-
cently, EVA-1, a conserved transmembrane protein with extra-
cellular domains that display similarity to sugar binding do-
mains, has been identified as an additional Slit/SLT-1
receptor that is required for Slit/SLT-1 signaling and physically
interacts with SLT-1 [20].
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1983DA/DB motor neurons and in particular DB7 do not require
slt-1 or eva-1 to make their correct guidance decision at the
midline while its canonical receptor sax-3/Robo is involved in
routing all DA/DB motor neurons (Figure 3D; Figure S1B).
These findings are consistent with previous findings demon-
strating that sax-3/Robo has functions that are independent
of its canonical ligand slt-1/Slit [7, 19] and imply that this
slt-1-independent function of sax-3/Robo is likewise indepen-
dent of eva-1. Intriguingly, loss of slt-1 significantly sup-
presses the axonal projection defects in DB7 as a result of
ectopically expressing hst-6 in the hypodermis (Figure 3F).
This suppression does not result from changes in expression
levels of either slt-1 or its canonical receptor sax-3 (Figure S5).
Thus, a possible interpretation of our data is that ectopic
6O-sulfated HS attached to LON-2/glypican instructs SLT-1
to misroute the DB7 motor axon by possibly promoting the in-
teraction of SLT-1 with a cognate receptor on motor neurons,
thereby misrouting an extending axon.
We next asked whether the slt-1/Slit receptor eva-1 could
serve as this cognate receptor in the context of DB7 misrout-
ing. Indeed, genetic removal of eva-1 significantly suppresses
the hst-6-dependent axonal misrouting of DB7 (Figure 3F).
With eva-1 expressed in eMNs [20], this genetic data is in ac-
cord with a scenario where HS of a specific modification status
instructs slt-1 to interact with eva-1, leading to an axonal
misrouting response of DB7. The misrouting of DB7 must be
largely sax-3 independent because the penetrance of defects
in the hst-6 misexpression strain (10.2%) and sax-3 loss-
of-function animals (19.8%) are additive in the strain carrying
the hst-6-misexpressing transgene in conjunction with the
sax-3 null mutation (34.3%) (compare Figures 3D and 3F).
This last finding implies potential sax-3-independent functions
for eva-1.
Discussion
Our analysis of the projection patterns of embryonic motor
axons in C. elegans reveals that superficially similar neuron
types are programmed to extend their axons in distinct direc-
tions through diverse mechanisms. In addition to a large num-
ber of guidance cues and intracellular signaling molecules,
which are involved in patterning motor axon projections at
the worm midline (data not shown), HS modifications play
a crucial role in determining the projection patterns of individ-
ual motor axons. Our findings indicate that HS modifications
have specific and instructive functions, likely through mediat-
ing specific ligand/receptor interactions (Figure 4).
This interpretation takes the broadly accepted concept into
account that extracellular HS molecules not only promote, but
are often essential for, the activity of specific ligand/receptor
systems [3]. In support of this notion, in vitro experiments sug-
gest that differentially modified HS can promote signaling
through distinct signaling systems [21, 22]. Together with our
finding that both the removal of enzymes that modify HS mol-
ecules as well as the ectopic addition of HS modifications
through misexpression of a HS-modifying enzyme causes mis-
routing defects, we propose that the local modification status
of HS in the vicinity of extending motor axons impinges on
which ligand/receptor system is engaged (Figure 4). This
model is consistent not only with the effects observed upon re-
moval of HS-modifying enzymes, but also with the genetic
analyses of animals with ectopic expression of hst-6 in the
hypodermis. In this scenario, the introduction of a novel
HS-modification pattern that is attached to a specific coreprotein in the hypodermis (LON-2) aberrantly promotes the in-
teraction of the repulsive SLT-1 cue with a receptor molecule,
possibly EVA-1, thereby causing a misorientation of motor
axon pathfinding (Figure 4). This is supported by our genetic
data demonstrating that genetic removal of lon-2, slt-1, or
eva-1 suppresses the misrouting defect in DB7 to levels that
are statistically indistinguishable from wild-type (Figures 3D–
3F). However, we note that this model is not the only way to in-
terpret the genetic interaction of ectopic hst-6 with lon-2, slt-1,
or eva-1. Indirect effects are conceivable and can not be ruled
out by genetic analysis alone.
With this caveat in mind, the finding that ectopic expression
of an HS-modifying enzyme and the dependence of the result-
ing phenotype on a specific axon-guidance molecule (slt-1) and
one of its receptors (eva-1) provides additional support for
a concept in which the enormous molecular complexity em-
bedded with HS molecules may carry not merely permissive
but also instructive information content. It has been speculated
before that the molecular diversity of HS molecules could pro-
vide a code that regulates the regiospecific activity of individual
axon-patterning systems [3, 5–7]. Specifically, in the HS code
hypothesis, regiospecific HS-modification patterns determine
the responsiveness of neurons to individual ligand/receptor
patterning cues. In accordance with this hypothesis, the
removal of individual modifications causes highly specific
nervous system-patterning defects [7, 23–25] (this study). Fur-
thermore, we show that the removal of combinations of HS
modifications uncovers cell-specific redundancies in the re-
quirements for HS modifications (Figure 2), indicating that the
presumptive HS code may be degenerate. And lastly, as
pointed out previously [13], an important additional criterion
for the existence of such a code is that HS modifications act in-
structively, and not merely as permissive cofactors. A genetic
test to determine the difference between instructiveness and
permissiveness is to ask whether a given gene not only
Wild type Ectopic 6O sulfation
Right extension Left extension
DB7
hypo hypo
DB7
SAX-3 SAX-3EVA-1 EVA-1
Ligand X SLT-1 Ligand X
SLT-1
LON-2
Figure 4. A Model for the Role of HS in Redirecting Axonal Projections
A possible interpretation of the genetic data presented in Figure 3. In
wild-type animals, slt-1 or eva-1 is not required for DB7 neuron projections
(as slt-1 and eva-1 mutants show no axonal defects; Figure 3D), whereas
sax-3 does normally have a role in DB7 axon extension (Figure 3D). In
wild-type animals, SAX-3 may therefore be interacting with an as yet
unknown ligand X. Upon introducing ectopic 6O-sulfation patterns (red
hatches), an interaction of the SLT-1 protein with EVA-1 may be promoted,
which supersedes the effect normally induced by SAX-3/Ligand X. We
emphasize that these conclusions are based on purely genetic arguments
and that more indirect mechanistic models can be envisioned that are not
shown here.
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1984displays a specific loss-of-function phenotype, but whether
a gain-of-function phenotype of the gene upon misexpression
can also instruct a novel phenotype [26]. Keeping in mind that
these experiments provide genetic rather than biochemical ev-
idence for the action of HS, our results clearly show that we can
redirect the DB7 neuron upon misexpression of the HS 6O-sul-
fotransferase hst-6. We can detect the molecular correlate of
this hst-6 misexpression in the hypodermis by using both an
HS-specific antibody and biochemical analyses of HS disac-
charides (Figure 2B; Figure S2). Moreover, we find that this
novel phenotype is dependent on a specific HS core protein
(lon-2/glypican) and that aberrant 6O-sulfation appears to acti-
vate slt-1 signaling through the slt-1 receptor eva-1 (Figures 3E
and 3F). Further biochemical studies are warranted to corrob-
orate these genetic results and to gain mechanistic insight
into how HS can misdirect axons.
Experimental Procedures
Neuroanatomical Scoring
All animals were scored at 20C in a mixed population of midlarval to adult
stages. DA/DB were scored with unc-129::gfp (evIs82b) and PVQ with sra-
6::gfp (oyIs14). GFP expression in the DA/DB neurons of evIs82b transgenic
animals is variable in DA7, DA8, and DA9; moreover, projection patterns of
DA1, DB1, and DB2 are often not easy to follow on the single-cell level and
we therefore excluded these neuron types from our analysis. Individual
motor neurons were identified based on their cell-body position and the
dorsal projection patterns. In each figure, the error bars denote the standard
error of proportion and asterisks indicate statistical significance: *p < 0.05,
**p < 0.005, ***p < 0.0005; n.s., not significant. Statistical significance was
calculated with the z-test. If multiple comparisons were made, p values
were subjected to the Bonferroni correction.
Transgenes
For ectopic hypodermal expression of HS-modifying enzymes, the com-
plete hst-6 and hst-2 loci were fused to the dpy-7 promoter [14] by PCR fu-
sion [27]. For the dpy-7prom::hst-6mut construct, the template for PCR fusion
was genomic DNA from OH281 [mgIs18; lon-2(e678)hst-6(ot17)], which
harbors a premature stop codon in hst-6 [28]. All constructs were injected
at 2.5 ng/ml into evIs82b (Is[unc-129::gfp]) with pceh-22::gfp at 50 ng/ml as
injection marker and pBS at 50 ng/ml as carrier.
Immunohistochemistry
Worms were prepared for immunohistochemistry with a freeze crack proto-
col [29] followed by 20 min fixations in ice-cold acetone and methanol, re-
spectively. Worms were then incubated for 30 min in PBS containing 10%
donkey serum and in the same buffer at 4C overnight with antibody
AO4B08 or HS4C3 (1:5) [15, 30]. The immunohistochemical stain was devel-
oped with the monoclonal anti-VSV antibody P5D4 (dilution 1:250) and
Alexa-labeled (555) donkey anti-mouse antibodies (dilution 1:250).
Supplemental Data
Supplemental Data include five figures and two tables and can be found
with this article online at http://www.current-biology.com/supplemental/
S0960-9822(08)01538-8.
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